Compounds > malondialdehyde
Page last updated: 2024-08-21

malondialdehyde and olmesartan medoxomil

malondialdehyde has been researched along with olmesartan medoxomil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Arslan, S; Demirkiliç, U; Güler, A; Inan, K; Onan, B; Oztaş, E; Sahin, MA; Tatar, H; Ucak, A; Uysal, B1
Giridharan, VV; Kodama, M; Lakshmanan, AP; Meilei, H; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Watanabe, K1
Ahmed, O; Alqurashi, T; Hussien, M; Murad, H1
Alqurashi, TM; Murad, HA1

Other Studies

4 other study(ies) available for malondialdehyde and olmesartan medoxomil

ArticleYear
Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats.
    Annals of vascular surgery, 2010, Volume: 24, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Constriction; Disease Models, Animal; Glutathione Peroxidase; Imidazoles; Male; Malondialdehyde; Motor Activity; Necrosis; Neuroprotective Agents; Olmesartan Medoxomil; Paraplegia; Rats; Rats, Wistar; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Superoxide Dismutase; Tetrazoles; Time Factors

2010
Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Dec-18, Volume: 44, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Glucose; Caspase 12; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney; Lipid Peroxidation; Malondialdehyde; Membrane Proteins; Mice; Olmesartan Medoxomil; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1; Superoxides; Tetrazoles; TNF Receptor-Associated Factor 2; Transcription Factor CHOP

2011
Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis in rats.
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cadherins; Caspase 3; Cell Adhesion; Colitis; Crohn Disease; Drug Delivery Systems; Interleukin-6; Malondialdehyde; Matrix Metalloproteinase 9; Olmesartan Medoxomil; Peroxidase; Rats; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2022
A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2023, Volume: 56

    Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Caspase 3; Duodenitis; Indomethacin; Interleukin-6; Male; Malondialdehyde; NF-kappa B; Olmesartan Medoxomil; Peroxidase; Rats; Rats, Wistar; Survivin; Tumor Necrosis Factor-alpha

2023